Serum Interleukin-34 in Psoriatic arthritis patients and its correlation with disease 1 activity, and subclinical atherosclerosis
Abstract Background Psoriatic arthritis (PsA) is a chronic multi-domains autoimmune inflammatory disorder. Patients with PsA have a significant prevalence of cardiovascular affection. Upregulated Interleukin-34 (IL-34) has been seen in many autoimmune disorders, and also in atherosclerotic plaques....
Main Authors: | Samar Abdalhamed Tabra, Mohammed Hassan Abu-Zaid, Radwa Mahmoud Elsharaby, Dina Maria, Samah ElMiedany |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-04-01
|
Series: | Egyptian Rheumatology and Rehabilitation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43166-023-00183-z |
Similar Items
-
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study
by: Andrea Becciolini, et al.
Published: (2023-02-01) -
Association of nuts and unhealthy snacks with subclinical atherosclerosis among children and adolescents with overweight and obesity
by: Maryam Aghayan, et al.
Published: (2019-04-01) -
Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis
by: Alexis Ogdie, et al.
Published: (2023-05-01) -
Preclinical Aortic Atherosclerosis in Adolescents With Chronic Disease
by: Francesca A. Ververs, et al.
Published: (2022-07-01) -
Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning
by: Rubén Queiro, et al.
Published: (2023-01-01)